Replicel Life Sciences Inc
XTSX:RP
Replicel Life Sciences Inc
XTSX:RP
Price:
0.015
CAD
50%
Market Closed
Market Cap:
CA$722.3k
Relative Value
The Relative Value of one
RP
stock under the Base Case scenario is
hidden
CAD.
Compared to the current market price of 0.015 CAD,
Replicel Life Sciences Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
RP Relative Value
HIDDEN
Multiples Across Competitors
RP Competitors Multiples
Replicel Life Sciences Inc Competitors
Replicel Life Sciences Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
Replicel Life Sciences Inc
XTSX:RP
|
722.3k CAD | 0 | -22 | -12.5 | -12.5 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
988.8B USD | 346.2 | 4 099.5 | 1 174.7 | 2 262 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
186.5B USD | 4.2 | 27.8 | 19.5 | 26.2 | |
| US |
|
Danaher Corp
NYSE:DHR
|
137.9B USD | 5.6 | 38.2 | 19.4 | 28.2 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
33.7B CHF | 5.2 | 35.6 | 26.5 | 26.5 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
265.7B CNY | 6 | 17.7 | 17.8 | 17.8 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
32.6B USD | 4.6 | 25.3 | 19.9 | 23.8 | |
| US |
|
Waters Corp
NYSE:WAT
|
29.2B USD | 9.2 | 45.4 | 29.3 | 36.9 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
29.1B USD | 1.8 | 21.5 | 11.9 | 17.9 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
25B USD | 6.2 | 28.8 | 21.4 | 23.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
